What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Open

Biosimilars in the EU – Information guide for healthcare professionals – unofficial Ukrainian translation now available

8 February 2021

External Resource

OPEN UNOFFICIAL UKRAINIAN TRANSLATION

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Factsheet

Open

The total clinical experience with biosimilar medicines exceeds 2 billion patient treatment days

16 December 2020

Infographic

Open

Biosimilar medicines are available in therapy areas which represent 65% of the biologics market by value

16 December 2020

Infographic

Open

In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

16 December 2020

Infographic

Open

Growing number of biologic therapies offers future opportunities for biosimilar development

16 December 2020

Infographic

Open

In Bavaria, biosimilar competition led to rheumatic patients receive faster access to biological therapy

16 December 2020

Infographic

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Subscribe to our newsletter